Docetaxel

国家: 新西兰

语言: 英文

来源: Medsafe (Medicines Safety Authority)

有效成分:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

可用日期:

REX Medical Ltd

INN（国际名称）:

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

剂量:

80 mg/mL

药物剂型:

Concentrate for infusion

组成:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

每包单位数:

Vial, glass, Diluent, 6 mL

类:

Prescription

处方类型:

Prescription

厂商:

Cipla Ltd

疗效迹象:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

產品總結:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

授权日期:

2006-06-23